Imaging as a biomarker in drug discovery for Alzheimer’s disease: is MRI a suitable technology?

This review provides perspectives on the utility of magnetic resonance imaging (MRI) as a neuroimaging approach in the development of novel treatments for Alzheimer’s disease. These considerations were generated in a roundtable at a recent Wellcome Trust meeting that included experts from academia a...

Descripción completa

Detalles Bibliográficos
Autores principales: Merlo Pich, Emilio, Jeromin, Andreas, Frisoni, Giovanni B, Hill, Derek, Lockhart, Andrew, Schmidt, Mark E, Turner, Martin R, Mondello, Stefania, Potter, William Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255417/
https://www.ncbi.nlm.nih.gov/pubmed/25484927
http://dx.doi.org/10.1186/alzrt276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255417/
https://www.ncbi.nlm.nih.gov/pubmed/25484927
http://dx.doi.org/10.1186/alzrt276

Ejemplares similares